#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Shprintzen-Goldberg syndrome Alagille syndrome White matter lesion Monogenic diabetes Congenital leptin deficiency Adenocarcinoma gastric Non-Hodgkin's lymphoma unspecified histology indolent Anal fistula Metastases to central nervous system Pleomorphic liposarcoma Hereditary haemorrhagic telangiectasia Cystic fibrosis respiratory infection suppression Necrotising enterocolitis neonatal Nephrotic syndrome HER2 gene amplification More trials…

    Learn about Rare Diseases

    Niemann-Pick disease – Basic Information Activated PI3 kinase delta syndrome – Trials in Disease Uterine leiomyosarcoma – Trials in Disease IgA nephropathy Hepatic angiosarcoma Bronchiolitis obliterans syndrome – Diagnostics Rhabdomyosarcoma recurrent – Diagnostics Angiosarcoma recurrent Vascular malformation – Trials in Disease Haemophilia B with anti factor IX – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Darbepoetin Alfa Apadamtase Alfa Eletriptan Iopromide Glucose Monohydrate Dfv890 MB-001 DESMOPRESSIN ACETATE Oxycodone Hydrochloride Metformin Embonate Golexanolone Rbl005.3 Vib1116 Etrasimod Arginine Prilocaine Ezabenlimab Nadroparin Calcium Gskvx000000008885 Leuprorelin Acetate Metoprolol More therapies…

    Learn about Your Condition

    Fibrous dysplasia of bone Impaired gastric emptying Loeys-Dietz syndrome Incontinence End stage renal disease Anogenital dysplasia MELAS syndrome Dementia with Lewy bodies Endometrial cancer stage IV Spermatocele Metachromatic leukodystrophy Lung disorder Peritoneal dialysis Lumbosacral radiculopathy Extraskeletal ossification More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Vaccine

  • Study on the Effects of Escherichia coli Nissle 1917 in Patients with Autoimmune Uveitis

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Autoimmune uveitis
    Investigated Drugs:
    • Escherichia Coli Strain Nissle 1917
    Czechia

  • Study on Eplerenone for Improving Kidney Function in Patients Undergoing Kidney Transplantation

    Recruiting

    3 1 1
    Investigated Diseases:
    • Renal transplant
    Investigated Drugs:
    • Eplerenone
    • Iohexol
    France

  • Study on Ethinylestradiol/Levonorgestrel and Vitamin E for Treating Menstrual and Perimenopausal Migraines in Women

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Alpha-Tocopherol
    • Ethinylestradiol
    • Levonorgestrel
    The Netherlands

  • Study Comparing Atezolizumab Alone and Atezolizumab with Bevacizumab for First-Line Treatment in Patients with Advanced Non-Small-Cell Lung Cancer

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Non-small cell lung cancer stage IV
    Investigated Drugs:
    • Bevacizumab
    • Atezolizumab
    Italy

  • Study on Statins for Frail Older Patients with Recent Ischemic Stroke or TIA: Fluvastatin, Simvastatin, Pravastatin Sodium, Atorvastatin, and Rosuvastatin Combination

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Ischaemic stroke
    Investigated Drugs:
    • Fluvastatin
    • Simvastatin
    • Atorvastatin
    The Netherlands

  • Study on Olaparib for Maintenance Therapy in Patients with Newly Diagnosed Advanced Ovarian, Fallopian Tube, and Peritoneal Cancer

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Ovarian cancer
    Investigated Drugs:
    • Olaparib
    Italy
Previous Page
1 … 299 300 301 302 303 … 1,650
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!